Rationale for and Design of the PARADIGM Study: Randomized Phase III Study of mFOLFOX6 Plus Bevacizumab or Panitumumab in Chemotherapy-naïve Patients With RAS (KRAS/NRAS) Wild-type, Metastatic Colorectal Cancer
| Image |  |
|---|---|
| Description | scientific article published on 24 January 2017 |
| Author/s |
author: Yoshito Komatsu Katsuya Tsuchihara Takayuki Yoshino Atsushi Ochiai Takeshi Naitoh |
| Publication date | January 24, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |